are glp 1 patches safe Do Work? The Honest Clinical Answer GLP-1 Patches': Are They Too

Description

The fact that it is now achievable with a weekly injection represents one of the most significant advances in metabolic medicine in decades

Among patients receiving concomitant sodiumglucose cotransporter-2 (SGLT2) inhibitors at baseline, no meaningful difference to those patients without concomitant SGLT2 inhibitor use was observed

Introduction In recent years, the glucagon-like peptide-1 receptor (GLP-1R) and its agonists (GLP-1RAs) have become central to medical research and treatment strategies

Although no data from head-to-head trials comparing retatrutide to other currently approved obesity treatments exist, data from the phase 2 studies with retatrutide suggest that at higher doses, retatrutide could lead to greater WL compared to the most efficacious approved treatments for obesity and T2D such as tirzepatide 15 mg and semaglutide 2.4 mg (Fig